申请人:ACADEMY OF MILITARY MEDICAL SCIENCES
公开号:US20220380402A1
公开(公告)日:2022-12-01
The present disclosure provides 6-hydrazinoadenosine represented by the general Formula (I) and its derivatives with A
2A
adenosine receptor agonist activity, and pharmaceutical compositions containing them. The compound and composition can be used as A
2A
adenosine receptor agonists and used as medicament.